Your browser doesn't support javascript.
loading
Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial.
Wartko, Paige D; Bobb, Jennifer F; Boudreau, Denise M; Matthews, Abigail G; McCormack, Jennifer; Lee, Amy K; Qiu, Hongxiang; Yu, Onchee; Hyun, Noorie; Idu, Abisola E; Campbell, Cynthia I; Saxon, Andrew J; Liu, David S; Altschuler, Andrea; Samet, Jeffrey H; Labelle, Colleen T; Zare-Mehrjerdi, Mohammad; Stotts, Angela L; Braciszewski, Jordan M; Murphy, Mark T; Dryden, Douglas; Arnsten, Julia H; Cunningham, Chinazo O; Horigian, Viviana E; Szapocznik, José; Glass, Joseph E; Caldeiro, Ryan M; Phillips, Rebecca C; Shea, Mary; Bart, Gavin; Schwartz, Robert P; McNeely, Jennifer; Liebschutz, Jane M; Tsui, Judith I; Merrill, Joseph O; Lapham, Gwen T; Addis, Megan; Bradley, Katharine A; Ghiroli, Megan M; Hamilton, Leah K; Hu, Yong; LaHue, Jennifer S; Loree, Amy M; Murphy, Sean M; Northrup, Thomas F; Shmueli-Blumberg, Dikla; Silva, Angela J; Weinstein, Zoe M; Wong, Mark TinFook; Burganowski, Rachael P.
Afiliação
  • Wartko PD; Kaiser Permanente Washington Health Research Institute, Seattle.
  • Bobb JF; Kaiser Permanente Washington Health Research Institute, Seattle.
  • Boudreau DM; Department of Biostatistics, School of Public Health, University of Washington, Seattle.
  • Matthews AG; Kaiser Permanente Washington Health Research Institute, Seattle.
  • McCormack J; Now with Genentech Inc, South San Francisco, California.
  • Lee AK; The Emmes Company, Rockville, Maryland.
  • Qiu H; The Emmes Company, Rockville, Maryland.
  • Yu O; Kaiser Permanente Washington Health Research Institute, Seattle.
  • Hyun N; Now with Kaiser Permanente Washington, Renton.
  • Idu AE; Kaiser Permanente Washington Health Research Institute, Seattle.
  • Campbell CI; Now with Department of Epidemiology and Biostatistics, Michigan State University, East Lansing.
  • Saxon AJ; Kaiser Permanente Washington Health Research Institute, Seattle.
  • Liu DS; Kaiser Permanente Washington Health Research Institute, Seattle.
  • Altschuler A; Kaiser Permanente Washington Health Research Institute, Seattle.
  • Samet JH; Division of Research, Kaiser Permanente Northern California, Oakland.
  • Labelle CT; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco.
  • Zare-Mehrjerdi M; Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, Washington.
  • Stotts AL; National Institute on Drug Abuse Center for Clinical Trials Network, North Bethesda, Maryland.
  • Braciszewski JM; Division of Research, Kaiser Permanente Northern California, Oakland.
  • Murphy MT; Boston University Schools of Medicine and Public Health, Boston Medical Center, Boston, Massachusetts.
  • Dryden D; Boston University Schools of Medicine and Public Health, Boston Medical Center, Boston, Massachusetts.
  • Arnsten JH; Department of Family and Community Medicine, UTHealth Houston McGovern Medical School, Houston, Texas.
  • Cunningham CO; Department of Family and Community Medicine, UTHealth Houston McGovern Medical School, Houston, Texas.
  • Horigian VE; Center for Health Policy and Health Services Research, Henry Ford Health, Detroit, Michigan.
  • Szapocznik J; MultiCare Health System, Tacoma, Washington.
  • Glass JE; MultiCare Health System, Tacoma, Washington.
  • Caldeiro RM; Now with Mosaic Medical, Bend, Oregon.
  • Phillips RC; Montefiore Medical Center, Bronx, New York.
  • Shea M; Albert Einstein College of Medicine, Bronx, New York.
  • Bart G; Albert Einstein College of Medicine, Bronx, New York.
  • Schwartz RP; Now with New York State Office of Addiction Services and Supports, New York.
  • McNeely J; Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, Florida.
  • Liebschutz JM; Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, Florida.
  • Tsui JI; Kaiser Permanente Washington Health Research Institute, Seattle.
  • Merrill JO; Mental Health and Wellness Department, Kaiser Permanente Washington, Renton.
  • Lapham GT; Kaiser Permanente Washington Health Research Institute, Seattle.
  • Addis M; Kaiser Permanente Washington Health Research Institute, Seattle.
  • Bradley KA; Department of Medicine, Hennepin Healthcare, Minneapolis, Minnesota.
  • Ghiroli MM; Friends Research Institute, Baltimore, Maryland.
  • Hamilton LK; Department of Population Health, Grossman School of Medicine, New York University, New York.
  • Hu Y; Center for Research on Health Care, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • LaHue JS; Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle.
  • Loree AM; Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle.
  • Murphy SM; Kaiser Permanente Washington Health Research Institute, Seattle.
  • Northrup TF; Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle.
  • Shmueli-Blumberg D; Kaiser Permanente Washington Health Research Institute, Seattle.
  • Silva AJ; Kaiser Permanente Washington Health Research Institute, Seattle.
  • Weinstein ZM; Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle.
  • Wong MT; Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, California.
JAMA Intern Med ; 183(12): 1343-1354, 2023 Dec 01.
Article em En | MEDLINE | ID: mdl-37902748
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Intern Med Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Intern Med Ano de publicação: 2023 Tipo de documento: Article